Rep. Julia Letlow Sells Icon Plc (NASDAQ:ICLR) Shares

Representative Julia Letlow (Republican-Louisiana) recently sold shares of Icon Plc (NASDAQ:ICLR). In a filing disclosed on March 12th, the Representative disclosed that they had sold between $1,001 and $15,000 in Icon stock on February 12th. The trade occurred in the Representative’s “MERRILL LYNCH INVESTMENT ACCOUNT #025” account.

Representative Julia Letlow also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of HF Sinclair (NYSE:DINO) on 2/20/2026.
• Sold $1,001 – $15,000 in shares of BXP (NYSE:BXP) on 2/20/2026.
• Purchased $1,001 – $15,000 in shares of Travelers Companies (NYSE:TRV) on 2/20/2026.
• Sold $1,001 – $15,000 in shares of Expand Energy (NASDAQ:EXE) on 2/17/2026.
• Sold $1,001 – $15,000 in shares of Public Service Enterprise Group (NYSE:PEG) on 2/17/2026.
• Purchased $1,001 – $15,000 in shares of Vistra (NYSE:VST) on 2/17/2026.
• Purchased $1,001 – $15,000 in shares of Regeneron Pharmaceuticals (NASDAQ:REGN) on 2/12/2026.
• Purchased $1,001 – $15,000 in shares of Extra Space Storage (NYSE:EXR) on 2/12/2026.
• Sold $1,001 – $15,000 in shares of AT&T (NYSE:T) on 2/12/2026.
• Sold $1,001 – $15,000 in shares of Broadcom (NASDAQ:AVGO) on 2/12/2026.

Icon Stock Up 0.1%

ICLR traded up $0.10 during midday trading on Wednesday, hitting $101.38. 251,193 shares of the company’s stock traded hands, compared to its average volume of 1,914,996. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.06 and a quick ratio of 1.06. The company has a market cap of $8.19 billion, a PE ratio of 13.72, a price-to-earnings-growth ratio of 2.57 and a beta of 1.35. The stock’s fifty day simple moving average is $131.28 and its 200-day simple moving average is $161.55. Icon Plc has a one year low of $66.57 and a one year high of $211.00.

Analyst Ratings Changes

ICLR has been the topic of several recent research reports. Barclays cut their target price on Icon from $200.00 to $120.00 and set an “equal weight” rating on the stock in a report on Monday, March 9th. Bank of America reissued an “underperform” rating and issued a $75.00 price objective on shares of Icon in a research note on Thursday, February 12th. Truist Financial restated a “hold” rating and issued a $222.00 target price (down from $231.00) on shares of Icon in a report on Thursday, January 8th. Zacks Research cut Icon from a “hold” rating to a “strong sell” rating in a research report on Wednesday, February 25th. Finally, Citigroup lowered their price target on Icon from $200.00 to $120.00 and set a “neutral” rating on the stock in a report on Wednesday, March 11th. Six research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, Icon currently has an average rating of “Hold” and a consensus price target of $146.80.

Hedge Funds Weigh In On Icon

Large investors have recently bought and sold shares of the stock. Muhlenkamp & Co. Inc. acquired a new stake in Icon during the third quarter worth $12,857,000. Mitchell Capital Management Co. bought a new position in shares of Icon during the 3rd quarter worth about $1,627,000. First National Bank of Omaha acquired a new stake in shares of Icon during the 3rd quarter valued at about $6,267,000. Tributary Capital Management LLC boosted its position in shares of Icon by 84.5% during the 3rd quarter. Tributary Capital Management LLC now owns 11,752 shares of the medical research company’s stock valued at $2,057,000 after acquiring an additional 5,381 shares in the last quarter. Finally, CIBC Bancorp USA Inc. bought a new stake in Icon in the third quarter valued at about $39,074,000. 95.61% of the stock is currently owned by institutional investors and hedge funds.

About Representative Letlow

Julia Letlow (Republican Party) is a member of the U.S. House, representing Louisiana’s 5th Congressional District. She assumed office on April 14, 2021. Her current term ends on January 3, 2027.

Letlow (Republican Party) is running for re-election to the U.S. House to represent Louisiana’s 5th Congressional District. She declared candidacy for the primary scheduled on November 3, 2026.

Julia Letlow earned a doctorate. Letlow’s career experience includes working as a senior administrator with the University of Louisiana at Monroe.

Icon Company Profile

Icon plc (NASDAQ: ICLR) is a global provider of outsourced drug development and clinical research services to the pharmaceutical, biotechnology and medical device industries. The company partners with clients at all stages of the product life cycle, offering expertise in protocol design, trial execution and regulatory compliance across a broad range of therapeutic areas.

Icon’s service portfolio encompasses clinical trial management, data management and biostatistics, medical imaging, pharmacovigilance and safety monitoring, laboratory sciences and specialized analytical solutions.